Old Web
English
Sign In
Acemap
>
authorDetail
>
Mathu Ruthra
Mathu Ruthra
Internal medicine
Adverse effect
Randomized controlled trial
Medicine
Asymptomatic
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Galectin Antagonist use in Mild Cases of SARS-CoV-2: Pilot Feasibility Randomised, Open Label, Controlled Trial
2021
Journal of Vaccines and Vaccination
Alben Sigamani
Mathu Ruthra
Sudhishma
Samarth Shetty
madhavi
Anup Chugani
Hana Chen-Walden
DavidPlatt
Thomas Kutty
Show All
Source
Cite
Save
Citations (0)
AYUSH medicine as add-on therapy for mild category COVID-19; an open label randomised, controlled clinical trial.
2020
medRxiv
Anusha Rao
Ranganatha R
Vikneswaran G
Sagar C
Mathu Ruthra
Sherin Manichen
Alben Sigamani
Ravi Kumar Reddy
Show All
Source
Cite
Save
Citations (0)
1